Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 5, 1998, Pages 1818-1820

  Minamikawa, Jun ^a   Tanaka, Satsuki ^a   Yamauchi, Mika ^a   Inoue, Daisuke ^a   Koshiyama, Hiroyuki ^a  

^a HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; SULFONYLUREA; TROGLITAZONE;

ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL DIAMETER; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; DRUG EFFECT; ECHOGRAPHY; FEMALE; HEMOGLOBIN DETERMINATION; HISTOPATHOLOGY; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

CAROTID ARTERIES; CHROMANS; DIABETES MELLITUS, TYPE 1; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; THIAZOLES; THIAZOLIDINEDIONES; TRIGLYCERIDES;

EID: 0031724132     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.5.1818     Document Type: Article

References (20)

1. Pujia A, Gnasso A, Irace C, Colonna A, Mattioli PL. 1994 Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care 17: 1330-1336.
2. Handa N, Matsumoto M, Maeda H, Hougaku H, Kamada T, for the OSACA Study Group. 1995 Ischemic stroke events and carotid atherosclerosis. Stroke 26:1781-1786.
3. Minamikawa J, Yamauchi M, Tanaka S, Koshiyama H. 1998 Carotid arterial intimal-medial thickening and plaque formation in NIDDM. Diabetes Care 21:323-324.
4. Minamikawa J, Yamauchi M, Inoue D, Koshiyama H. 1998 Another potential use of troglitazone in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab (in press).
5. Fukunaga Y, Minamikawa J, Inoue D, Koshiyama H, Fujisawa I. 1997 Pseudoacromegaly and hyperinsulinemia: a possibility of premature atherosclerosis? J Clin Endocrinol Metab 82:3515-3516.
6. Folsom AR, Eckfeldt JH, Weitzman S, et al, 1994 Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Stroke 25:66-73.
7. Stout RW, Vallancc-Owen J. 1969 Insulin and atheroma. Lancet i: 1078-1080.
8. Reaven GM, Chen Y-DI. 1996 Insulin resistance, its consequences, and coronary heart disease: must we choose one culprit? Circulation 93:1780-1783.
9. Ghazzi MN, Perez JE, Antonucci TK, et al. 1997 Cardiac and glycemic benefits of troglitazone treatment in NIDDM. Diabetes 46:433-439.
10. Law RE, Meehan WP, Xi X-P, et al. 1997 Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia. J Clin Invest 98:1897-1905.
11. Salonen R, Nyssönen K, Pokkala E, et al. 1995 Kuopio Atherosclerosis Prevention Study (KAPS): a popoluation-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 92:1758-1764.
12. Mercuri M, Bond G, Veglia F, et al. 1996 Pravastatin reduced carotid intima-media thickness progression in an asymptomatic hypercholesterolemic Mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med 101:627-634.
13. Ogihara T, Rakugi H, Ikegami H, Mikami H, Masuo K. 1995 Enhancement of insulin sensitivity by troglitazone lowers blood pressure in diabetic hypertensives. Am J Hypertens 8:316-320.
14. Suter SL, Nolan JJ, Wallace P, Gumbiner B, Olefsky JM. 1992 Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care 15:193-203.
15. Ryu JE, Howard G, Craven TE, Bond MG, Hagman AP, Crouse III JR. 1992 Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects. Stroke 23:823-828.
16. Howard G, O'Leary DH, Zaccaro D, et al. 1996 Insulin sensitivity and atherosclerosis. Circulation 93:1809-1817.
17. Borona E, Tessari R, Micciolo R, et al. 1997 Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Diabetes Care 20:627-631.
18. Stern MP. 1995 Diabetes and cardiovascular disease: the "common soil hypothesis" Diabetes 44:369-374.
19. Feener EP, King GL. 1997 Vascular dysfunction in diabetes mellitus. Lancet 350: SI9-SI13
20. Cominacini L, Garbin U, Pastorino AM, et al. 1997 Effects of troglitazone on in vitro oxidation of LDL and HDL induced by copper irons and endothelial cells. Diabetologia 40:165-172.